ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,811Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 337

$458K Total Retail Price of All Prescriptions

Rank: 88 out of 337

544 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 544 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 544 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,573 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 643 523 1 1
LISINOPRIL 572 544 2 2
OMEPRAZOLE 455 368 3 4
LEVOTHYROXINE SODIUM 325 248 4 5
ATORVASTATIN CALCIUM 299 295 5 7
HYDROCHLOROTHIAZIDE 278 261 6 9
HYDROCODONE-ACETAMINOPHEN 254 199 S3 7 13
AMLODIPINE BESYLATE 227 212 8 3
ATENOLOL 214 193 9 10
CITALOPRAM HBR 204 154 10 17
METOPROLOL TARTRATE 165 163 11 6
DIOVAN 141 141 12 26
FUROSEMIDE 129 115 13 8
ZOLPIDEM TARTRATE 125 124 14 23
SERTRALINE HCL 106 91 15 18
METFORMIN HCL 105 94 16 12
WARFARIN SODIUM 95 93 17 11
LIPITOR 94 94 18 33
DOXAZOSIN MESYLATE 90 84 19 68
LOSARTAN POTASSIUM 89 85 20 15
AZITHROMYCIN 77 67 21 51
CLOPIDOGREL 74 59 22 42
NEXIUM 73 70 23 56
TRAZODONE HCL 73 40 23 16
GLIMEPIRIDE 70 59 25 55
GABAPENTIN 70 61 25 20
METOPROLOL SUCCINATE 69 62 27 21
ALLOPURINOL 69 67 27 28
PROAIR HFA 66 52 29 38
ADVAIR DISKUS 60 49 30 44
GLIPIZIDE 60 60 30 45
MIRTAZAPINE 59 55 32 27
PRAVASTATIN SODIUM 53 48 33 14
RANITIDINE HCL 53 31 33 30
VERAPAMIL ER 52 52 35 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.